Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis with pulmonary hypertension.

Rolla, G; Colagrande, P; Brussino, L; Bucca, C; Bertero, M T; Caligaris-Cappio, F

Rolla, G; Colagrande, P; Brussino, L; Bucca, C; Bertero, M T; Caligaris-Cappio, F.

Lancet ; 351(9114): 1491-2, 1998 May 16.

Article in En | MEDLINE | ID: mdl-9605813

Subject(s)

Hypertension, Pulmonary/metabolism; Iloprost/pharmacology; Nitric Oxide/metabolism; Scleroderma, Systemic/complications; Vasodilator Agents/pharmacology; Administration, Inhalation; Breath Tests; Female; Humans; Hypertension, Pulmonary/etiology; Iloprost/administration & dosage; Middle Aged; Nitric Oxide/analysis; Vasodilator Agents/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Scleroderma, Systemic / Vasodilator Agents / Iloprost / Hypertension, Pulmonary / Nitric Oxide Type of study: Etiology_studies Limits: Female / Humans / Middle aged Language: En Journal: Lancet Year: 1998 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links